| Pharmaceutical active ingredients: |
| Ranolazine |
| Available forms, composition and doses of Ranexa: |
| Tablets, Extended Release; Oral; Ranolazine 1 gTablets, Extended Release; Oral; Ranolazine 500 mgTablets; Oral; Ranolazine 1 gTablets; Oral; Ranolazine 500 mg |
| Ranexa medical category: |
| Human:Anti-anginal drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| MenariniBerlin-ChemieCV TherapeuticsGilead |
| Related documents and information about Ranexa: |
| Ranexa prescribing information (PDF) |